Megacystis-microcolon-intestinal hypoperistalsis and prune belly: overlapping syndromes

Terry L Levin1, Lamia Soghier, Netta M Blitman

  • 1Department of Radiology, Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467-2490, USA. jebl@aol.com

Pediatric Radiology
|August 4, 2004
PubMed

Insights

Megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIHS) is a rare condition. This case report details a male infant diagnosed with both MMIHS and prune belly syndrome (PBS), suggesting a potential shared pathogenesis.

Area of Science:

  • Pediatric Surgery
  • Medical Genetics

Background:

  • Megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIHS) is a rare, often fatal congenital disorder affecting the gastrointestinal tract and bladder.
  • Prune Belly Syndrome (PBS), also known as Eagle-Barrett syndrome, is characterized by abdominal muscle laxity, urinary tract abnormalities, and undescended testes.

Observation:

  • MMIHS typically presents in female infants with a functional GI obstruction, malrotation, microcolon, and a large bladder.
  • Shared features between MMIHS and PBS include hydronephrosis, bladder distension, and abdominal wall laxity.
  • Familial occurrence of both MMIHS and PBS suggests a possible common genetic or developmental pathway.

Findings:

  • This report describes a unique case of a male infant diagnosed with both MMIHS and true PBS.
  • The co-occurrence of these two rare conditions in a single patient provides novel insights into their potential shared etiology.

Implications:

  • This case highlights the importance of considering overlapping features and potential shared pathogenesis between MMIHS and PBS.
  • Further research into the genetic and molecular mechanisms underlying both conditions may lead to improved diagnostic and therapeutic strategies.
  • Understanding the interplay between MMIHS and PBS can advance the field of pediatric urogenital and gastrointestinal disorders.

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Diverticular Disease of the Colon01:27

Diverticular Disease of the Colon

Diverticular disease involves the formation of diverticula—small sac-like outpouchings of the colonic wall—and their complications. It most commonly affects the sigmoid colon due to higher intraluminal pressure and structural vulnerability. It results from structural weakness and increased pressure in the colon, producing pseudodiverticula that may remain silent or progress to inflammation and serious complications.Structure of DiverticulaIn diverticulosis, these outpouchings are...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...